Treat-to-target Endpoint Definitions in Systemic Lupus Erythematosus: More Is Less?

被引：6
|
作者：
Morand, Eric F. [1 ,2 ]
Golder, Vera [3 ]
机构：
[1] Monash Univ, Sch Clin Sci, Clayton, Vic, Australia
[2] Monash Hlth, Rheumatol, Melbourne, Vic, Australia
[3] Monash Hlth, Melbourne, Vic, Australia
来源：
JOURNAL OF RHEUMATOLOGY | 2019年 / 46卷 / 10期
关键词：
DISEASE-ACTIVITY STATE; RHEUMATOID-ARTHRITIS; REMISSION; RECOMMENDATIONS; SLE;
D O I：
10.3899/jrheum.190223
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1256 / 1258
页数：3
相关论文
共 50 条
  • [41] Development of an IL-17A DNA Vaccine to Treat Systemic Lupus Erythematosus in Mice
    Koriyama, Hiroshi
    Ikeda, Yuka
    Nakagami, Hironori
    Shimamura, Munehisa
    Yoshida, Shota
    Rakugi, Hiromi
    Morishita, Ryuichi
    VACCINES, 2020, 8 (01)
  • [42] Retinal Drusen Are More Common and Larger in Systemic Lupus Erythematosus With Renal Impairment
    Ham, Ye Ji
    Nicklason, Eleanor
    Wightman, Tony
    Akom, Sarah
    Sandhu, Kieran
    Harraka, Philip
    Colville, Deb
    Catran, Andrew
    Barit, David
    Langsford, David
    Pianta, Tim
    Foote, Andrew
    Buchanan, Russell
    Mack, Heather
    Savige, Judy
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (04): : 848 - 856
  • [43] The patient's perspective: are quality of life and disease burden a possible treatment target in systemic lupus erythematosus?
    Kernder, Anna
    Elefante, Elena
    Chehab, Gamal
    Tani, Chiara
    Mosca, Marta
    Schneider, Matthias
    RHEUMATOLOGY, 2020, 59 : 63 - 68
  • [44] Systemic Lupus Erythematosus Monocytes Are Less Responsive to Interleukin-10 in the Presence of Immune Complexes
    Yuan, Weijia
    DiMartino, Stephen J.
    Redecha, Patricia B.
    Ivashkiv, Lionel B.
    Salmon, Jane E.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (01): : 212 - 218
  • [45] Less than 7 hours of sleep per night is associated with transitioning to systemic lupus erythematosus
    Young, K. A.
    Munroe, M. E.
    Harley, J. B.
    Guthridge, J. M.
    Kamen, D. L.
    Gilkensen, G. S.
    Weisman, M. H.
    Karp, D. R.
    Wallace, D. J.
    James, J. A.
    Norris, J. M.
    LUPUS, 2018, 27 (09) : 1524 - 1531
  • [46] The Complex Role of Gut Microbiota in Systemic Lupus Erythematosus and Lupus Nephritis: From Pathogenetic Factor to Therapeutic Target
    Parodi, Emanuele
    Novi, Marialuisa
    Bottino, Paolo
    La Porta, Edoardo
    Merlotti, Guido
    Castello, Luigi Mario
    Gotta, Franca
    Rocchetti, Andrea
    Quaglia, Marco
    MICROORGANISMS, 2025, 13 (02)
  • [47] Drug Allergies May Be More Frequent in Systemic Lupus Erythematosus Than in Rheumatoid Arthritis
    Javier Aceves-Avila, Francisco
    Benites-Godinez, Veronica
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2008, 14 (05) : 261 - 263
  • [48] Polymorphonuclear Neutrophils in Rheumatoid Arthritis and Systemic Lupus Erythematosus: More Complicated Than Anticipated
    Ahmad, Ahmad Haidar
    Melbouci, Dyhia
    Decker, Patrice
    IMMUNO, 2022, 2 (01): : 85 - 103
  • [49] Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis - A Survey of Pediatric Rheumatologists and Nephrologists in Germany and Austria
    Vollbach, Kristina
    Schuetz, Catharina
    Hedrich, Christian M.
    Speth, Fabian
    Moenkemoeller, Kirsten
    Brunner, Juergen
    Neudorf, Ulrich
    Rietschel, Christoph
    Hospach, Anton
    Kallinich, Tilmann
    Hinze, Claas
    Wagner, Norbert
    Toenshoff, Burkhard
    Weber, Lutz T.
    Latta, Kay
    Thumfart, Julia
    Bald, Martin
    Wiemann, Dagobert
    Zappel, Hildegard
    Tenbrock, Klaus
    Haffner, Dieter
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [50] Treat-to-target strategies aiming at additional ultrasound remission is associated with better control of disease activity and less flare in rheumatoid arthritis
    Yan Geng
    Liujun Wang
    Xiaohui Zhang
    Lanlan Ji
    Xuerong Deng
    Zhuoli Zhang
    Clinical Rheumatology, 2021, 40 : 113 - 121
12345